The prostaglandin (PG) receptors EP4 and FP have the potential to exert negative effects on adipogenesis, but the exact contribution of endogenous PG-driven receptor signaling to this process is not fully understood. In this study, we employed an adipocyte differentiation system from mouse embryonic fibroblasts (MEFs), and compared the effects of each PG receptor-deficiency on adipocyte differentiation. In wild-type (WT) MEFs, inhibition of endogenous PG synthesis by indomethacin augmented the differentiation, and exogenous PGE 2 as well as an FP-agonist reversed the effect of indomethacin. In EP4-deficient cells, basal differentiation was up-regulated to the levels in indomethacin-treated WT cells and indomethacin did not further enhance differentiation. Differentiation in FP-deficient cells was equivalent to WT and was still sensitive to indomethacin. PGE 2 or indomethacin treatment of WT MEFs for the first two days was enough to suppress or enhance transcription of the Pparg2 gene as well as the subsequent differentiation, respectively. Differentiation stimuli induced COX-2 gene and protein expression, as well as PGE 2 production in WT MEFs. These results suggest that PGE 2 -EP4 signaling suppresses adipocyte differentiation by affecting Pparg2 expression in an autocrine manner, and FP-mediated inhibition is not directly involved in adipocyte differentiation in the MEF system.
Introduction
Adipogenesis is a crucial aspect in controlling body fat mass (1, 2) .
Acquisition of the mature adipocyte phenotype is a highly regulated process in which mesenchymal stem cells (MSCs) undergo differentiation, resulting in both an increase in size and number of mature adipocytes in adipose tissue. Adipose tissue is not only important for energy storage but is also an endocrine organ that regulates energy homeostasis by secreting various adipokines, such as cytokines, chemokines, growth factors and lipid mediators (3) . The presence of receptors for adipokines in preadipocytes and adipocytes has been shown, suggesting that secreted adipokines have autocrine effects and regulate their own differentiation and functions (4) . Although it has been shown that a number of factors including adipokines regulate adipogenesis in various settings, most of the evidence comes from supra-physiological or pharmacological doses of these molecules to elicit a response. Hence, their physiological significance in local milieu has not been established.
Prostaglandins (PGs) are arachidonate metabolites synthesized by the action of cyclooxygenase (COX) as the rate-limiting enzyme. COX has been shown to exist as two isomers, COX-1 and COX-2. PGs exert a wide range of actions through their binding to plasma membrane receptors (5, 6) . For instance, PGF 2α exerts its actions via specific interactions with the prostanoid FP receptor, which activates phopholipase C, resulting in phophatidylinositol breakdown (7) . In contrast, PGE 2 exerts its actions through its interaction with four PGE 2 receptor subtypes (EPs; EP1, EP2, EP3 and EP4).
The EP subtypes differ in their signal transduction pathways; EP1 is coupled to the by guest, on November 9, 2017 www.jlr.org Downloaded from mobilization of intracellular [Ca 2+ ], EP2 and EP4 are coupled to the stimulation of adenylyl cyclase and phosphoinositide 3-kinase (PI-3 kinase) (8) , and EP3 is mainly coupled to the inhibition of adenylyl cyclase. The diverse actions of PGE 2 can be explained by the existence of these multiple EP subtypes with different signal transduction pathways (6, 9) . It has been shown that COX products such as PGE 2 and PGF 2α inhibit adipocyte development (10) (11) (12) . A recent study suggested that COX-2 may be involved in body fat regulation (13) . Mice heterozygous for the COX-2 gene showed approximately 30% increased body weight, with 2-3-fold larger fat pads compared with those of wild-type animals. PGE 2 production in adipose tissue from COX-2 null mice was only 20% of that of wild-type mice. These results suggest that COX-2 as well as PGE 2 participates in the negative regulation of adipocyte differentiation. Indeed, we previously identified that PGE 2 -EP4 signaling suppresses adipocyte differentiation from 3T3-L1 preadipocytes (14, 15) . In contrast, PGF 2α has also been shown to suppress adipocyte differentiation from 3T3-L1 preadipocytes via the FP receptor (11) . Thus, both PGF 2α and PGE 2 have the potential to suppress adipogenesis through FP and EP4, respectively. However, it has not been fully examined as to whether PGF 2α and/or PGE 2 are produced in preadipocytes as a kind of adipokine and control adipocyte differentiation in an autocrine manner.
As a first step to elucidate the physiological roles of EP4-and FP-mediated regulation of adipocyte differentiation and maturation, we employed an adipocyte differentiation system from mouse embryonic fibroblasts (MEFs), and compared the effects of each receptor-deficiency on adipocyte differentiation.
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Materials and Methods
Mice. Specific-pathogen-free, C57BL/6 mice were obtained from Japan SLC (Hamamatsu, Japan). Mice were maintained on a 12-h light, 12-h dark cycle under specific-pathogen-free conditions. Ptger4
-/-and their control wild-type (WT) mice with a mixed background of 129SV and C57BL/6 were littermates of offspring from heterozygote crosses (16) . Ptgfr -/-mice with a genetic background of C57BL/6 were generated as described (17, 18) , and C57BL/6 mice were used as WT controls. Reactions were started by the addition of test reagents along with 100 µM Ro-20-1724.
After incubation for 10 min (Fig. 2 , B and C) or 1 h (Fig. 3E) during the differentiation program ( Fig. 1 , B-D). In both cell groups, TGs were undetected on day 2, slight but significant levels of TGs were detected on day 4, and then levels drastically increased on day 6 and 8. However, at every time point, the TG levels in indomethacin-treated cells were significantly higher by 2-fold than control cells (Fig. 1B) . In both groups, the oil droplets became visible on day 4, but the number of droplet + cells were constant until day 8 ( 
Expression of PG receptors in MEF cells
We next examined the mRNA expression of PG receptors in MEF cells during the differentiation program ( Fig. 2A ). EP1 and EP4 mRNAs were expressed during the differentiation period. In addition, among the PGE receptor subtypes, significant expression of EP4 mRNA was detected throughout the differentiation process. We failed to detect a significant amount of EP2 receptor mRNA in these cells. 2D ). Thus, both EP4 and FP receptors have the potential to suppress differentiation.
Since indomethacin treatment facilitates differentiation, either EP4 and/or FP signaling may endogenously suppress adipocyte differentiation in MEF cells.
EP4-deficiency but not FP-deficiency mimics the enhancing effect of indomethacin on adipocyte differentiation
To examine which receptor signaling suppresses adipocyte differentiation from MEF cells, we prepared MEF cells isolated from Ptger4 -/-and Ptgfr -/-mice, and examined the outcome of DIC-induced adipocyte differentiation. Interestingly,
EP4-deficient cells revealed higher levels of TG content on day 8 than wild-type (WT)
cells, and such levels were equivalent to those of indomethacin-treated WT cells (Fig.   3A) . Similar results were obtained regarding Pparg2 gene expression levels in the cells on day 8 (Fig. 3B) . Moreover, the number of droplet + cells in EP4-deficient cells was higher than WT cells and similar to that of indomethacin-treated WT cells (Fig. 3C ).
Indeed, EP4 deficiency increased the total expression levels of lipolytic (Lipe) and lipogenic (Fasn) genes and did not affect TG content per cell as observed in indomethacin-treated WT cells (data not shown). Indomethacin did not further augment the total TG content, droplet + number, and Pparg2 expression levels in EP4-deficient cells ( Fig. 3 . A-C). Moreover, an EP4 antagonist (1 µM) but not an EP1 or EP3
antagonist mimicked the enhancing effect of indomethacin on differentiation (Fig. 3D ).
When we measured cAMP content in the cells on day 0, indomethacin as well as an EP4 Fig. 2B ). These results indicate that PGF 2α -FP signaling is not involved in the suppression of adipocyte differentiation, although FP signaling has the potential to be involved. Thus, endogenous PGE 2 -EP4 signaling appears to suppress adipocyte differentiation in MEF cells.
Endogenous PGE 2 -EP4 signaling suppresses transcription of the Pparg2 gene on day 2 of adipocyte differentiation
It has been considered that the destiny of each cell is determined during the could reverse the effect of indomethacin. PGE 2 treatment for the first 2 days significantly suppressed the levels of TG content and Pparg2 expression, but an FP agonist failed to alter these levels (Fig. 4, C and D) . These results indicate that endogenous PGE 2 -EP4 signaling suppresses the differentiation stage of adipogenesis.
We next investigated the time course of induction of the Pparg2 gene, which is a prerequisite for the commitment of individual cells to adipocyte differentiation in the MEF system (Fig. 4E) . Pparg2 expression was drastically induced by DIC treatment, reaching a peak level on day 2 until the DIC was removed, and then gradually decreased until day 8. If suppressive PG signaling dominates the fate of differentiation during the first 2 days, indomethacin may alter the peak level of Pparg2 gene expression on day 2.
As expected, indomethacin significantly augmented Pparg2 gene expression on day 2.
Moreover, PGE 2 but not an FP agonist reversed the enhancing effect of indomethacin on Pparg2 transcription (Fig. 4F ). These results indicate that endogenous PGE 2 -EP4 signaling suppresses adipocyte differentiation by attenuating transcription of the Pparg2 gene.
DIC treatment induces COX-2 expression and PGE 2 production
The above studies demonstrated that endogenous PGE 2 -EP4 signaling reduces which reached a peak at 3 h and then gradually decreased. Such DIC-induced PGE 2 production was inhibited by indomethacin (Fig. 5A) . In good accordance with this, DIC transiently induced Ptgs2 gene expression in MEF cell reaching a peak at 1 h. In contrast, Ptgs1 gene expression was observed in MEF cells irrespective of DIC treatment (Fig. 5B) . Indeed, COX-1 protein expression was detected in MEF cells before DIC treatment, and DIC did not alter its levels. COX-2 protein could barely be detected in MEF cells before DIC treatment, but a faint and significant amount was detected at 1 and 3 h after the addition of DIC, respectively (Fig. 5C ). Thus, DIC rapidly induces COX-2 and PGE 2 production in MEF cells in an indomethacin-sensitive manner. If COX-2-derived PGE 2 is involved in the negative regulation of adipocyte differentiation, a selective inhibitor for COX-2 should mimic the facilitating effect of indomethacin. As expected, NS398, a COX-2 selective inhibitor augmented the levels of TG content, whereas SC560, a COX-1 selective inhibitor failed to do so (Fig. 5D ).
These results indicate that in MEF cells the differentiation-inducing stimuli induce COX-2 expression and PGE 2 production, and the resultant PGE 2 , via acting on the EP4 receptor negatively regulates adipocyte differentiation by reducing the peak level of Pparg2 gene induction.
Discussion
PGE 2 -EP4 signaling endogenously suppresses adipocyte differentiation from MEF cells
PGs have long been thought to contribute to fat cell development, but the role whereas PGE 2 inhibits differentiation via the EP4 receptor (14, 15) . PGF 2α also suppresses differentiation via the FP receptor (11, 14) . In the current study, we evaluated the contribution of each endogenous receptor signaling by using an adipocyte differentiation system from MEFs, where pharmacological actions on the PG receptor EP4 and FP signaling were reproduced as reported previously: exogenously added PGE 2 and an FP agonist suppressed adipocyte differentiation (Fig. 2, D 
and E). Inhibition of endogenous PG synthesis by indomethacin increased the number of TG-producing cells
and transcription of the Pparg2 gene (Fig. 1, C and E), suggesting that suppressive PG signaling (EP4 or FP) dominates the fate of differentiation. EP4 deficiency mimicked the effect of indomethacin, and indomethacin no longer accelerated the differentiation (Fig. 3 , A-C), whereas FP deficiency failed to affect differentiation, and indomethacin was still effective (Supplementary Fig. 2 ). PGE 2 treatment for 2 days was enough to suppress differentiation (Fig. 4 ., C and D). Indeed, indomethacin increased and PGE 2 suppressed the peak level of Pparg2 gene transcription on day 2, which is critical for the commitment of individual cells to differentiation (Fig. 4F) . These results indicate that PGE 2 -EP4 signaling suppresses transcription of the Pparg2 gene and thus the adipocyte differentiation of MEFs ( Supplementary Fig. 3 ). PGF 2α -FP signaling appears to have the potential to affect adipocyte differentiation, but FP signaling is not involved by guest, on November 9, 2017 www.jlr.org
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in the differentiation system of MEFs ( Supplementary Fig. 2 ). Considering that treatment of MEFs with an FP agonist for the first 2 days fails to alter both TG content and Pparg2 gene expression (Fig. 3, C and D) , PGF 2α -FP signaling may work as a compensatory negative regulator of the maturation stage of adipocyte differentiation ( Supplementary Fig. 3 ).
Differentiation stimuli-induced COX-2 gene expression and PGE 2 production in MEF cells
The current study demonstrates that COX-2 is responsible for PGE 2 
EP3 receptor gene expression is induced upon adipocyte differentiation
One of the interesting findings in this study is differentiation-dependent induction of EP3 gene expression; the expression of three isoforms (α, β and γ) of EP3 mRNA was equally induced when MEF cells were differentiated into mature adipocytes.
Similar results were previously reported; mRNA of the three isoforms of EP3 were expressed exclusively in mature adipocytes isolated from mouse adipose tissue (28).
Although the EP3γ isoform may have the potential to activate the Gs/adenylyl cyclase pathway (21), activation of the EP3 receptor resulted in inhibition of cAMP production in adipocyte-differentiated MEFs (Fig. 2C) . Indeed, PGE 2 -EP3 signaling has been shown to inhibit lipolysis by suppression of cAMP production (29). Since the adipocyte-specific phospholipase A 2 (Pla2g16 product) works as a trigger for PGE 2 production in mature adipocytes, and since the Pla2g16 gene expression also depends on adipocyte differentiation (30), it is possible that the Pla2g16 and Ptger3 genes share common mechanisms in their regulation of expression during adipocyte differentiation.
PGE 2 -EP4 signaling may elicit reciprocal actions on adipogenesis and osteogenesis from mesenchymal stem cells
Adipocytes and osteoblasts represent two distinct cell types that develop from a common progenitor cell, bone marrow-derived mesenchymal stem cells (MSCs) (31).
The number of osteoblasts in bone marrow is known to decrease during age-related bone loss (osteoporosis), and the number of adipocytes has been found to increase in 
